-
EP2954891
European procedure
Extract from the Register of European Patents
EP About this file: EP2954891
| EP2954891 - INHALATION COMPOSITION CONTAINING ACLIDINIUM FOR TREATMENT OF ASTHMA [Right-click to bookmark this link] | Status | No opposition filed within time limit Status updated on 10.03.2023 Database last updated on 11.05.2024 | |
| Former | The patent has been granted Status updated on 02.04.2022 | ||
| Former | Grant of patent is intended Status updated on 23.11.2021 | ||
| Former | Examination is in progress Status updated on 16.10.2021 | ||
| Former | Grant of patent is intended Status updated on 06.06.2021 | ||
| Former | Examination is in progress Status updated on 24.02.2017 | Most recent event Tooltip | 10.03.2023 | No opposition filed within time limit | published on 12.04.2023 [2023/15] | Applicant(s) | For all designated states Almirall, S.A. Ronda del General Mitre 151 08022 Barcelona / ES | [2015/51] | Inventor(s) | 01 /
LAMARCA CASADO, Rosa C/de la Llacuna 110-112, 1º 3a 08018 Barcelona / ES | 02 /
DE MIQUEL SERRA, Gonzalo P.O. Box 08029 Avda. Diagonal 511, 3º 3ª Barcelona / ES | [2015/51] | Representative(s) | J A Kemp LLP 80 Turnmill Street London EC1M 5QU / GB | [2022/18] |
| Former [2015/51] | Srinivasan, Ravi Chandran J A Kemp 14 South Square Gray's Inn London WC1R 5JJ / GB | Application number, filing date | 15173011.6 | 13.03.2009 | [2015/51] | Priority number, date | EP20080382010 | 13.03.2008 Original published format: EP 08382010 | [2015/51] | Filing language | EN | Procedural language | EN | Publication | Type: | A1 Application with search report | No.: | EP2954891 | Date: | 16.12.2015 | Language: | EN | [2015/51] | Type: | B1 Patent specification | No.: | EP2954891 | Date: | 04.05.2022 | Language: | EN | [2022/18] | Search report(s) | (Supplementary) European search report - dispatched on: | EP | 02.11.2015 | Classification | IPC: | A61K9/14, A61K45/06, A61K31/46, A61K9/72, A61P11/06 | [2021/23] | CPC: |
A61K31/439 (EP,KR,US);
A61K31/46 (EP,RU,US);
A61K9/0075 (EP,KR,RU,US);
A61K31/167 (EP,US);
A61K45/06 (EP,KR,US);
A61K9/14 (RU);
A61K9/145 (KR);
A61P11/00 (EP);
A61P11/06 (EP,KR);
| C-Set: |
A61K31/167, A61K2300/00 (EP,US);
A61K31/46, A61K2300/00 (US,EP) |
| Former IPC [2015/51] | A61K9/14, A61K9/72, A61K31/46, A61K45/06, A61K9/00 | Designated contracting states | AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, SE, SI, SK, TR [2016/30] |
| Former [2015/51] | AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, SE, SI, SK, TR | Extension states | AL | 16.06.2016 | BA | 16.06.2016 | RS | 16.06.2016 | Title | German: | INHALATIONSZUSAMMENSETZUNG ENTHALTEND ACLIDINIUM ZUR BEHANDLUNG VON ASTHMA | [2015/51] | English: | INHALATION COMPOSITION CONTAINING ACLIDINIUM FOR TREATMENT OF ASTHMA | [2015/51] | French: | COMPOSITION À INHALER COMPRENANT ACLIDINIUM POUR LE TRAITEMENT DE L'ASTHME | [2021/23] |
| Former [2015/51] | COMPOSITION À INHALER COMPRENANT DE L'ACLIDINIUM POUR LE TRAITEMENT DE L'ASTHME | Examination procedure | 16.06.2016 | Amendment by applicant (claims and/or description) | 16.06.2016 | Examination requested [2016/30] | 27.02.2017 | Despatch of a communication from the examining division (Time limit: M06) | 07.12.2017 | Reply to a communication from the examining division | 23.03.2018 | Despatch of a communication from the examining division (Time limit: M06) | 17.12.2018 | Reply to a communication from the examining division | 04.04.2019 | Despatch of a communication from the examining division (Time limit: M06) | 12.11.2019 | Despatch of communication that the application is deemed to be withdrawn, reason: reply to the communication from the examining division not received in time | 10.01.2020 | Reply to a communication from the examining division | 08.07.2020 | Date of oral proceedings | 15.07.2020 | Minutes of oral proceedings despatched | 20.07.2020 | Despatch of communication that the application is refused, reason: substantive examination {1} | 07.06.2021 | Communication of intention to grant the patent | 15.10.2021 | Disapproval of the communication of intention to grant the patent by the applicant or resumption of examination proceedings by the EPO | 24.11.2021 | Communication of intention to grant the patent | 07.03.2022 | Fee for grant paid | 07.03.2022 | Fee for publishing/printing paid | 07.03.2022 | Receipt of the translation of the claim(s) | Appeal following examination | 16.09.2020 | Appeal received No. T2015/20 | 16.11.2020 | Statement of grounds filed | 23.02.2021 | Result of appeal procedure: remittal for grant | 02.03.2021 | Despatch of the decision of the Board of Appeal | Parent application(s) Tooltip | EP09719213.2 / EP2265257 | Opposition(s) | 07.02.2023 | No opposition filed within time limit [2023/15] | Request for further processing for: | The application is deemed to be withdrawn due to failure to reply to the examination report | 10.01.2020 | Request for further processing filed | 10.01.2020 | Full payment received (date of receipt of payment) Request granted | 21.01.2020 | Decision despatched | The application is deemed to be withdrawn due to failure to reply to the examination report | 17.12.2018 | Request for further processing filed | 17.12.2018 | Full payment received (date of receipt of payment) Request granted | 08.01.2019 | Decision despatched | The application is deemed to be withdrawn due to failure to reply to the examination report | 07.12.2017 | Request for further processing filed | 07.12.2017 | Full payment received (date of receipt of payment) Request granted | 20.12.2017 | Decision despatched | Fees paid | Renewal fee | 19.06.2015 | Renewal fee patent year 03 | 19.06.2015 | Renewal fee patent year 04 | 19.06.2015 | Renewal fee patent year 05 | 19.06.2015 | Renewal fee patent year 06 | 19.06.2015 | Renewal fee patent year 07 | 31.03.2016 | Renewal fee patent year 08 | 27.03.2017 | Renewal fee patent year 09 | 27.03.2018 | Renewal fee patent year 10 | 27.03.2019 | Renewal fee patent year 11 | 27.03.2020 | Renewal fee patent year 12 | 29.03.2021 | Renewal fee patent year 13 | 28.03.2022 | Renewal fee patent year 14 |
| Opt-out from the exclusive Tooltip competence of the Unified Patent Court | See the Register of the Unified Patent Court for opt-out data | ||
| Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court. | Documents cited: | Search | [A]WO0236106 (BOEHRINGER INGELHEIM PHARMA [DE], et al) [A] 1-17* example A3; claims 1,5,9,10 *; | [Y]WO2005115465 (ALMIRALL PRODESFARMA SA [ES], et al) [Y] 1-17 * page 1, paragraph 1 - paragraph 4 * * page 2, paragraphs 2-3 * * page 9, paragraph 5 - page 10, paragraph 3 * * page 12, paragraph 4 * * page 23, paragraph 3 * * page 32, paragraph 3 * * page 32, paragraph l - page 33, paragraph 1; examples 1,2 *; | [Y] - G. JOOS ET AL., "Bronchodilator effects of aclidinium bromide, a novel long-acting anticholinergic, in COPD patients: a phase II study", (20070916), pages 209S - 210S, URL: http://www.ersnet.org/learning_resources_player/abstract_print_07/files/138.pdf, (20080710), XP002487868 [Y] 1-17 * page 210S, column R * | Examination | - KJELL LARSSON, "Aspects on pathophysiological mechanisms in COPD", JOURNAL OF INTERNAL MEDICINE, GB, (20070901), vol. 262, no. 3, doi:10.1111/j.1365-2796.2007.01837.x, ISSN 0954-6820, pages 311 - 340, XP055347678 DOI: http://dx.doi.org/10.1111/j.1365-2796.2007.01837.x | - Anonymous, "Duaklir Genuair 340 micrograms /12 micrograms inhalation powder", www.medicines.org.uk, (20180305), pages 1 - 14, URL: https://www.medicines.org.uk/emc/product/3562/smpc/print, (20190328), XP055575534 | - SINGH D ET AL, "A randomised, placebo- and active-controlled dose-finding study of aclidinium bromide administered twice a day in COPD patients", PULMORNARY PHARMACOLOGY & THERAPEUTICS, ACADEMIC PRESS, GB, vol. 25, no. 3, doi:10.1016/J.PUPT.2012.03.008, ISSN 1094-5539, (20120329), pages 248 - 253, (20120404), XP028483905 DOI: http://dx.doi.org/10.1016/j.pupt.2012.03.008 | by applicant | GB2041763 | EP0069715 | EP0166294 | GB2165159 | WO9102558 | EP0424790 | GB2242134 | WO9200771 | WO9203175 | WO9204068 | WO9204928 | WO9209322 | EP0505321 | US5201308 | DE4239402 | EP0674533 | WO9700703 | WO0104118 | WO03000325 | WO03061742 | WO03097613 | WO2004058729 | WO2005049581 | WO2005123693 | WO2005123692 |